Reminder: Invitation to Roche’s virtual event on key hematology data presented at ASH 2020 Dienstag, 01. Dezember 2020 - 14:21
Investor Update |
We are pleased to invite investors and analysts to participate in our virtual event on Tuesday, 8 December, 2020, highlighting Roche data presented at the virtual American Society of Hematology (ASH) 62nd Annual Meeting, from 5-8th December.
16:00 – 17:00 CET / 15:00 - 16:00 GMT
10:00 – 11:00 am EST / 7:00 – 8:00 am PST
The webinar will start with a presentation, followed by a Q&A session (live access to the speakers).
Agenda:
Welcome
Karl Mahler, Head of Investor Relations and Roche Group Planning
Hematology franchise overview
Tom Fuchs, Vice President, Hematology Franchise Head, Global Product Strategy
Review of key clinical data presented at ASH
Ginna Laport, Vice President & Global Head of Hematology NHL/CLL
Marion Ott, M.D., PhD - Global Franchise Head AML, Multiple Myeloma and Pediatric Development
Q&A
Access to virtual event (pre-registration required)
Please pre-register for our webinar here*.
A replay of the event will be available via > ir.roche.com
Best regards, |
|
Karl Mahler | Loren Kalm |
|
|
Roche Investor Relations |
|
Dr. Karl Mahler | Dr. Sabine Borngräber |
Dr. Bruno Eschli | Dr. Birgit Masjost |
Dr. Gerard Tobin | Jon Kaspar Bayard |
|
|
Investor Relations North America |
|
Loren Kalm | Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
Attachment
All rights reserved ©2020 F. Hoffmann-La Roche Ltd.
Group Communications, Grenzacherstrasse 124, CH-4070 Basel, Switzerland